Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

Round 2 Amgen? US FDA accepts Sandoz's Enbrel biosimilar for review

A second Sandoz biosimilar has been accepted for review by US FDA setting the stage for another potential legal battle with Amgen.

TPP: Five years data protection for biologics in US-Asia trade deal

Biologic drugs will be given a minimum of five years of data protection under the TPP trade deal agreed today, upsetting industry groups which had campaigned for 12.

UK's CPI opens doors for SMEs at new biologics manufacturing centre

The £38m ($58m) National Biologics Manufacturing Centre has opened its doors offering bioprocessing space to SMEs in the UK.

Government education grant to help grow Texas bioprocessing industry

Austin Community College has received a Government grant to establish a centre for biotechnology technicians it hopes will provide skilled workers for the Texas biomanufacturing industry.

PRA teams with site network for better adult vaccine trials

CRO PRA Health Sciences is working with trial site group AMR for better vaccine studies and shorter development times.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...